Perpetua Medical AB (publ)

Total Valuation

Perpetua Medical AB (publ) carries a market capitalization of 18.77M, placing it among publicly traded companies globally. Its enterprise value stands at 9.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Perpetua Medical AB (publ) currently has 8.56M shares outstanding.

Valuation Ratios

Perpetua Medical AB (publ) trades at a trailing price-to-earnings ratio of 11.45. The price-to-sales ratio is 1.19, and the price-to-book ratio stands at 9.47.

Enterprise Valuation

The EV/Sales ratio of 0.59 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 49.67 provides insight into valuation relative to core operating earnings.

Financial Position

Perpetua Medical AB (publ) maintains a current ratio of 5.28, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.62, indicating moderate leverage, while an interest coverage ratio of 0.24 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Perpetua Medical AB (publ)'s stock has declined approximately -22.06573% over the past 52 weeks. The 50-day moving average sits at 3.60, while the 200-day moving average is 4.16.

Income Statement

Over the trailing twelve months, Perpetua Medical AB (publ) generated 16.32M in revenue and converted that into 1.70M in net income, yielding earnings per share of -0.07. EBITDA reached 194,000.00, while operating income came in at 194,000.00.

Balance Sheet

Perpetua Medical AB (publ) holds 20.28M in cash and equivalents against 178,000.00 in total debt, resulting in a net debt position of -20.11M. Total book value stands at 2.05M, with working capital of 27.81M providing operational flexibility.

Cash Flow

Perpetua Medical AB (publ) produced -5.42M in operating cash flow over the past twelve months. After subtracting -3.10M in capital expenditures, free cash flow totaled -8.53M - equivalent to -1.51 per share.

Margins

Perpetua Medical AB (publ) operates with a gross margin of 53.54, reflecting its pricing power and cost economics. The operating margin of 1.19 and net profit margin of 10.41 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Perpetua Medical AB (publ)'s most recent stock split took place on September 26, 2024 with a 1000000:41667 split ratio.

Scores

Perpetua Medical AB (publ) posts an Altman Z-Score of 1.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.